An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to ...

By Sriparna Roy (Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in ...

Shares in both companies were lower after one study met the primary goal and a second missed its main target in their drug ...

Some patients with a rare form of ALS benefited from an experimental therapy, with biomarker evidence of reduced injury to neurons and even limited functional recovery.

EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for ...

An experimental drug developed at Duke University School of Medicine could offer powerful pain relief without the dangerous ...

When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he ...

An experimental drug known as ulefnersen has shown remarkable efficacy in treating a rare, aggressive form of ALS ...

Regeneron shares fell nearly 13% before the bell on Friday after its experimental drug for patients with a type of lung ...